Stay updated on Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Significant update: added current operating status notice, current date, expanded study listing header with 2025-09-11 details, and revision v3.2.0; removed old date 2024-12-17 and revision v3.1.0.
    Difference
    14%
    Check dated 2025-10-06T04:24:55.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Changed the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.
    Difference
    0.2%
    Check dated 2025-09-28T23:46:07.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Core content now shows Revision: v3.0.2 replacing v3.0.1. The Back to Top link was removed (minor UI change).
    Difference
    0.6%
    Check dated 2025-09-14T18:45:32.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.6%
    Check dated 2025-09-07T13:09:33.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, while removing specific location details such as state, country, and city information.
    Difference
    38%
    Check dated 2025-08-31T06:18:10.000Z thumbnail image
  9. Check
    78 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T21:00:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus MK-4830 in Ovarian Cancer Clinical Trial page.